NCAPD3 and neoplasm: From the experimental data, we found that the size and weight of xenograft tumors of NCAPD3-overexpression group were evidently larger when compared to control group (Fig. 6A, B), while the tumor size and weight were significant decreased in NCAPD3-overexpression following treatment with 2-DG group as compared to NCAPD3-overexpression group (Fig. 6A, B).